Total Payments
$11,646
2024 Payments
$9,076
Companies
22
Transactions
120
Medicare Patients
5,619
Medicare Billing
$413,726
Payment Breakdown by Category
Consulting$7,400 (63.5%)
Food & Beverage$3,142 (27.0%)
Travel$1,024 (8.8%)
Education$79.99 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,400 | 1 | 63.5% |
| Food and Beverage | $3,142 | 113 | 27.0% |
| Travel and Lodging | $1,024 | 5 | 8.8% |
| Education | $79.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,785 | 29 | $0 (2024) |
| Incyte Corporation | $1,005 | 8 | $0 (2021) |
| ABBVIE INC. | $668.84 | 35 | $0 (2024) |
| GENZYME CORPORATION | $228.06 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $200.47 | 7 | $0 (2024) |
| Genentech USA, Inc. | $128.55 | 1 | $0 (2019) |
| Lilly USA, LLC | $88.93 | 5 | $0 (2024) |
| PFIZER INC. | $72.61 | 5 | $0 (2024) |
| Almirall LLC | $62.76 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $49.94 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,076 | 52 | Novartis Pharmaceuticals Corporation ($8,497) |
| 2023 | $361.16 | 17 | Novartis Pharmaceuticals Corporation ($211.62) |
| 2022 | $356.65 | 10 | GENZYME CORPORATION ($140.23) |
| 2021 | $109.08 | 5 | AbbVie Inc. ($77.12) |
| 2020 | $47.67 | 2 | GENZYME CORPORATION ($28.74) |
| 2019 | $472.12 | 10 | AbbVie, Inc. ($215.75) |
| 2018 | $215.27 | 15 | PFIZER INC. ($51.89) |
| 2017 | $1,008 | 9 | Incyte Corporation ($985.48) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Immunology | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Immunology | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $7,400.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,414 | 2,567 | $173,096 | $110,642 |
| 2022 | 17 | 1,541 | 2,773 | $190,392 | $118,469 |
| 2021 | 15 | 1,174 | 2,002 | $146,559 | $90,366 |
| 2020 | 15 | 1,490 | 2,373 | $151,354 | $94,250 |
Total Patients
5,619
Total Services
9,715
Medicare Billing
$413,726
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 394 | 606 | $53,257 | $35,041 | 65.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 203 | 247 | $26,891 | $19,292 | 71.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 180 | 233 | $23,039 | $13,258 | 57.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 192 | 276 | $17,805 | $8,369 | 47.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 28 | $8,154 | $6,455 | 79.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 74 | $9,100 | $6,314 | 69.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 53 | 98 | $4,772 | $3,560 | 74.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 27 | 34 | $4,959 | $3,355 | 67.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 32 | $5,505 | $3,352 | 60.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 137 | 758 | $4,863 | $3,306 | 68.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 29 | $6,804 | $2,730 | 40.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 51 | $2,787 | $1,851 | 66.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $2,365 | $1,623 | 68.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $1,765 | $1,358 | 77.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 18 | $975.66 | $738.14 | 75.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 50 | $53.15 | $39.20 | 73.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 367 | 513 | $45,816 | $30,575 | 66.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 212 | 254 | $28,558 | $19,727 | 69.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 159 | $20,093 | $12,942 | 64.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 170 | 219 | $22,383 | $12,622 | 56.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 212 | 284 | $19,104 | $8,047 | 42.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 21 | 22 | $6,496 | $5,188 | 79.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 34 | 42 | $10,464 | $4,456 | 42.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 63 | 112 | $5,959 | $4,380 | 73.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 20 | 34 | $5,746 | $4,107 | 71.5% |
About Dr. Dhwani Mehta, MD
Dr. Dhwani Mehta, MD is a Dermatology healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1598197832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dhwani Mehta, MD has received a total of $11,646 in payments from pharmaceutical and medical device companies, with $9,076 received in 2024. These payments were reported across 120 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($7,400).
As a Medicare-enrolled provider, Mehta has provided services to 5,619 Medicare beneficiaries, totaling 9,715 services with total Medicare billing of $413,726. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Concord, NC
- Active Since 08/08/2013
- Last Updated 05/29/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1598197832
Products in Payments
- COSENTYX (Drug) $472.93
- SKYRIZI (Biological) $227.89
- DUPIXENT (Biological) $205.03
- TREMFYA (Drug) $199.19
- RINVOQ (Biological) $181.00
- Erivedge (Biological) $128.55
- XOLAIR (Drug) $124.89
- Skyrizi (Biological) $99.28
- COSENTYX (Biological) $76.83
- EUCRISA (Drug) $72.61
- TALTZ (Drug) $67.20
- Seysara (Drug) $50.63
- Sotyktu (Drug) $49.94
- Otezla (Drug) $46.05
- ADBRY (Biological) $42.71
- Humira (Biological) $39.26
- Bimzelx (Biological) $33.77
- HUMIRA (Biological) $28.90
- DUPIXENT DUPILUMAB INJECTION (Biological) $24.63
- DUPIXENT (Drug) $23.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Concord
William Hoover, Md, MD
Dermatology — Payments: $651,837
Dermatology $651,837
Dr. Heather Holahan, Md, MD
Dermatology — Payments: $15,616
Dermatology $15,616
Dr. Lacey Walls, D.o, D.O
Dermatology — Payments: $11,558
Dermatology $11,558
Andrew Kim, Md, MD
Dermatology — Payments: $11,195
Dermatology $11,195
Nava Greenfield, Md, MD
Dermatology — Payments: $10,175
Dermatology $10,175
Dr. Alexis Perkins, Md, MD
Dermatology — Payments: $7,068
Dermatology $7,068